Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer (2)

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer (2)

Metastatic Gastric Adenocarcinoma or Cancer (2)

Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma (2)

Active, not recruiting (2)

phase 3 (2)

Astellas Pharma Global Development, Inc. (2)

oxaliplatin (2)

placebo (2)

zolbetuximab (2)

capecitabine (1)

fluorouracil (1)

folinic acid (1)

drug (2)

Industry (2)

Interventional (2)

locally advanced unresectable gastric adenocarcinoma or cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
+3 more

Jan 16, 2023

Active, not recruiting

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
+3 more

Aug 16, 2022